A phase I trial of the trifunctional anti Her2 × anti CD3 antibody ertumaxomab in patients with advanced solid tumors - Hänse, Nicole; Marmé, Frederik; Haag, Georg Martin (BMC cancer, 2016)
Gesehen am 15.01.2019